Country Progress Report LAO PDR

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Improving diagnosis TB laboratory strengthening.
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
1 [INSERT COUNTRY NAME HERE] Introduction to the National MDR-TB Control Strategy SESSION 1 Insert country/ministry logo here.
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
TB Seminar 2014 Agenda and issues in NTP M&E System ARUN GAUTAM, CHIEF, PME SECTION, NTC.
Country Progress Report Philippines
Introduction Thailand one of 22 countries which contain 80% of the estimated tuberculosis (TB) cases in the world. Thailand ranks 17 th among the 22 high-burden.
Country Progress Report VIET NAM
Early and Improved TB case detection through the use of GeneXpert technology in Nepal.
Nepal TB REACH Project Wave 2 Year 1 (Nov Dec 2012) Year 2 (Jan 2013 – Jun 2014)
Technical Advisory Group meeting, WHO/WPRO
China TB Control Progress Report The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western Pacific Region.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Module 1: Course Overview. Course Objectives Teach you everything you need to know about the TB Program Describe TB the roles and responsibilities of.
National TB/ Leprosy Programme Manager
CITAM+ Engaging HIV Civil Society in TB ACSM Meeting, Cancun 30 Nov 2009 Carol Nawina Nyirenda National Coordinator Community Initiative for TB, HIV/AIDS.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
1 TB/HIV Project in the Philippines Yumiko Yanase.
One SADC, One Vision, One Way Working Together Towards MDG 6: SADC’s Common Vision Hon. Benedict Xaba, Minister of Health of Swaziland International AIDS.
Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory.
Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.
“World TB day and TB in Mongolia”
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
Our vision: Healthier communities, Excellence in healthcare Our values: Teamwork, Honesty, Respect, Ethical, Excellence, Caring, Commitment, Courage DOTS.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
DOTS-PLUS IN TANZANIA: PREPARATION PHASE Global DOTS Expansion Working Group Meeting, Paris: 28 October 2004 NTLP - MOH Prepared by: Dr. S. M. Egwaga NTLP.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
PMDT expansion is first of all expansion of DR-TB detection services Workshop on the development and implementation of supervision and patient support.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
DEWG Meeting Geneva 14 October 2009 TB in children Report from the breakout session.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
TB Control Measures: From development and endorsement to adoption and implementation Léopold Blanc TBS Stop TB department WHO Christy Garcia University.
Country Progress Report (Papua New Guinea) The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western.
World Health Organization, Western Pacific Regional Office Session 2 Laboratory strengthening Dr Cornelia Hennig Stop TB and Leprosy Elimination World.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
National Tuberculosis Control Program in Bangladesh : Progress Report Dr. Shamim Sultana Deputy Programme Manager, TB National TB Control Programme.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
TB infection control and prevention of XDR Group II.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Sisaket Province Case Finding
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Stop TB in China Challenges, Constraints & Actions Dr Wang Longde Vice Minister of Health China 24 March 2004.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
ADDRESSING MDR-TB: The PHILIPPINE EXPERIENCE
Taipei, June Content  Introduction about Vietnam’s Programmatic Management of Drug resistant Tuberculosis (PMDT) and drug resistant tuberculosis.
CAMBODIA Application to the Global Fund New Funding Model Tom Hiatt Global TBTEAM meeting June 2014.
TB- HIV Collaborative activities in Romania- may 2006 status
Country Progress Report Cambodia
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Knowledge gaps in formulating TB Control Policies for Prisons
Key issues in DOTS implementation
Update on SBCC Activities of Challenge TB Bangladesh
5th edition NTP MANUAL OF PROCEDURES Introduction and Highlights
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Presentation transcript:

Country Progress Report LAO PDR The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western Pacific Region Manila, Philippines 9 -12 December 2014

TB Epidemiology WHO Global Tuberculosis Report 2014

Major successes DOTS started in 1995 with WHO and Damien Foundation Belgium In 5 central, 17 provincial, 142 districts hospitals and 903 health centres (95%) and 175 private clinics and pharmacies (PSI) 4124 notified TB cases (2013) and treatment success rate 90% (2012) First TB prevalence survey in 2010 and first external TB review in 2013 Culture started in 2010 and DST in 2014 GeneXpert in 2 central hospitals and 1 provincial hospital (Savannakhet) 76% TB patients have HIV test result (Q3 2014) PMDT started in 2011: 25 MDR-TB patients on 9 month regimen (July 2013-Nov 2014) The NSP 2015-2019 is based on prevalence survey and TB review findings and recommendation to increase TB case detection

TB prevalence survey 1. Census 2. Interview 3. Specimen collection 3. Chest X-Ray

Major challenges Stagnation in TB detection (31% CDR all forms, 2013) Low identification and referral of presumptive TB in some provinces/districts Low referral by OPD, IPD, MCH etc. Child TB is under diagnosed TB HIV collaboration is still limited MDR is under diagnosed and often late Low sensitivity of direct microscopy Lack of information of the population on TB Insufficient involvement of community Managerial constraints (funding, infrastructure, procurement, administrative procedures)

Case detection stagnation Notification rates of tuberculosis in Lao PDR, 1995-2013 stagnation Source: NTC

National TB Strategic Plan 2015-2019 Aligned with National Health Sector Plan Budgeted Funded mostly by Global Fund (NFM request for 2015-2017) and other partners (WHO, DFB, USAID): LAO PDR NTP will be member of the Mekong Basin Disease Surveillance Vision: zero deaths, disease and suffering due to TB Goal: To reduce TB burden and to reach the targets of WHO Post-2015 Global Tuberculosis Strategy (adopted by 67th World Health Assembly 2014 on 19 May 2014) Specific target: Increase TB case detection rate (CDR) from 31% in 2013 to 70% in 2019 Objectives: Integrated patient centred TB care and prevention Strengthening TB-HIV collaborative activities Managing drug resistant tuberculosis (PMDT) Improved management

TB detection in Lao PDR, forecast 2015-2019

Laboratory strengthening LED: not significant advantage compared to ZN in Lao context of low work load Xpert MTB/RIF: 30% yield compared to microscopy (as a first test, NRL April-Nov 2014) GeneXpert scaling-up: cumulative 10 in 2014 (being procured), 15 in 2015, 20 in 2016 EQA microscopy since 2004, QA Culture and DST with KIT as SRL Laboratory information management system TA partners: WHO, Stop TB partnership, KIT, Merieux Foundation

Scaling-up Xpert MTB/RIF testing in Lao PDR

Reach the unreached: intensive case finding Engaging all health providers in public (OPDs, IPDs, MCH, ANC etc. and private sector) at all levels of the PHC ICF among house hold TB contacts including children, PLWH, prisoners, mine workers, mobile population, factories, patient with diabetes and other co-morbidities, ACF mobile camps in high prevalence areas (with CXR and GeneXpert) Diagnosis and treatment of child-TB Identify and refer all presumptive TB patients to the TB unit or to the TB laboratory Support health centres (training, supervision, budget for transportation of specimens) Advocate to local authority, chiefs of villages, village health committees to involve in TB control activities Use NGOs/CBOs (LYU, LOPHA, MAAP, PEDA, PSI)

Patient centred care: involvement of patients and civil society All stakeholders, public sector, donors, partners, NGOs/CBOs, key affected population and patients representatives provided their input in situation analysis, NSP elaboration and country dialogue (workshops) TB technical working group (TWG) includes NGOs/CBOs and partners NGOs/CBOs conduct joint need assessment surveys with local authorities to identify at risk population and explore gaps and barriers in accessing TB services NGOs/CBOs mobilize village health committees, chiefs of villages and villagers for TB case detection and sending patients/specimens in relation with the health centres and to participate in ACF campaigns NTP supports specimen transportation from health centres to TB laboratory

TB/VIH Collaboration with CHAS (planning, training and supervision) Rapid HIV testing for all TB patients (77% in 2014, target 100%) Coordination with CHAS for CPT and early ART among all TB-HIV patients «3 Is » among the PLWH: Intensive case finding, infection control and IPT *2014: projection of 3Q, NTC data

PMDT Achieved Target Presumptive MDR-TB patients examined by Xpert MTB/RIF or culture/DST (retreatment) 60% 100% RR/MDR-TB patients enrolled 90% 9 months MDR treatment: 25 MDR-TB patients under treatment in Dec 2014 25 35 in 2014, 40 in 2015, 45 in 2016, 50 in 2017 Surveillance (DRS in 2015) In preparation with KIT 2015 MDR-TB patients support for transportation, food, examinations Follow-up and care of adverse drugs events (report to FDD) Report severe ADE to FDD Cohort event monitoring (2015) Training of all physicians on PMDT (including diagnosis, treatment and infection control) Central level Train all provinces by 2015 Infection Control (administrative, environment, personal protection) Training of limited number of staff Train health staff at all levels on IC Data management E-RR under development Electronic R/R in 2015

Surveillance Quality of surveillance system: EQA microscopy established since 2004 QA culture and DST with KIT DRS to be conducted in 2015 New case definition rolled out in new national TB guidelines 3 rd edition (2014) e-R&R: under development for MDR-TB Analysis and usage of data at national and sub-national levels: briefing and debriefing meeting of NTP supervisors LAO PDR NTP will become member of the Mekong Basin Disease Surveillance (cross-border information and collaboration on TB control)

Policies and supportive systems TB care financing and social protection: social protection is limited to only 10-15% of the population Strengthening notification mechanism: Training all physicians and nurses in TB wards, OPD, IPD in public and private hospitals, in health centres, village health volunteers (VHV) and village health workers (VHW), private clinics and pharmacists paper based RR system to be upgraded to electronic RR Drug regulations: No change since drug regulation meeting in March 2014

Management Supervising all levels (central, province, district hospitals and health centre) and visit TB patients Improving communication, reporting and feed back (web based R/R) Train staff of all levels on administration, finances and reporting Ensure procurement, maintenance, logistic and storage

Partners

Thank you